Literature DB >> 9988481

Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus.

E Skrzypek1, C Cowan, S C Straley.   

Abstract

The YopM virulence protein of Yersinia pestis has been described as binding human alpha-thrombin and inhibiting thrombin-induced platelet aggregation in vitro. However, recent studies have shown that a YopM-CyaA fusion protein could be targeted vectorially into eukaryotic cells through the Yersinia type III secretion system. In this study, our objective was to characterize YopM's fate in more detail. We followed YopM in the culture medium and inside infected HeLa cells. We confirmed that the native YopM is targeted into HeLa cells, where it is insensitive to exogenous trypsin. The bacteria must be surface located to target YopM, and YopB and YopD are necessary, whereas the LcrE protein (called also YopN) makes this process more efficient. Immunofluorescence localization revealed that YopM, in contrast to YopE, is not only targeted to the cytoplasm but also trafficks to the cell's nucleus by means of a vesicle-associated pathway that is strongly inhibited by brefeldin A, perturbed by monensin or bafilomycin A1 and dependent upon microtubules (decreased by colchicine and nocodazole). These findings revealed a novel interaction of Yersinia pestis with its eukaryotic host.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9988481     DOI: 10.1046/j.1365-2958.1998.01135.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  51 in total

1.  Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes.

Authors:  A Gauthier; M de Grado; B B Finlay
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 2.  Molecular and cell biology aspects of plague.

Authors:  G R Cornelis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS.

Authors:  Matthew J Riese; Joseph T Barbieri
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 4.  Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae.

Authors:  Raphael H Valdivia
Journal:  Eukaryot Cell       Date:  2004-08

5.  A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis.

Authors:  Danielle L Jessen; David S Bradley; Matthew L Nilles
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

6.  LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism.

Authors:  K A Fields; S C Straley
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.

Authors:  Yue Zhang; Joseph T Barbieri
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Generation of the Brucella melitensis ORFeome version 1.1.

Authors:  Amélie Dricot; Jean-François Rual; Philippe Lamesch; Nicolas Bertin; Denis Dupuy; Tong Hao; Christophe Lambert; Régis Hallez; Jean-Marc Delroisse; Jean Vandenhaute; Ignacio Lopez-Goñi; Ignacio Moriyon; Juan M Garcia-Lobo; Félix J Sangari; Alastair P Macmillan; Sally J Cutler; Adrian M Whatmore; Stephanie Bozak; Reynaldo Sequerra; Lynn Doucette-Stamm; Marc Vidal; David E Hill; Jean-Jacques Letesson; Xavier De Bolle
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

9.  Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.

Authors:  Moritz Hentschke; Laura Berneking; Cristina Belmar Campos; Friedrich Buck; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

10.  In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.

Authors:  Tracy L DiMezzo; Gordon Ruthel; Ernst E Brueggemann; Harry B Hines; Wilson J Ribot; Carol E Chapman; Bradford S Powell; Susan L Welkos
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.